Detection ofM. tuberculosisDNA in TB contacts’ PBMC does not associate with blood RNA signatures for incipient tuberculosis

Author:

Rosenheim Joshua,Abebe Markos,Belay Mulugeta,Tulu Begna,Tayachew Dawit,Tegegn Metasebia,Younis Sidra,Jolliffe David A.,Aseffa Abraham,Ameni Gobena,Reece Stephen T,Noursadeghi MahdadORCID,Martineau Adrian RORCID

Abstract

ABSTRACTBackgroundWe have previously reported detection of genomic DNA ofMycobacterium tuberculosis(Mtb) in peripheral blood mononuclear cells (PBMC) of asymptomatic adults with recent household exposure to an index case of infectious pulmonary tuberculosis (TB). It is not known whether this phenomenon indicates quiescent Mtb infection or incipient TB disease.MethodsWe did a cross-sectional study with a nested prospective component, utilizing blood samples collected from a previously studied cohort of TB contacts recruited in Ethiopia to detect eight different blood RNA signatures for incipient TB. Gene expression analysis was performed on baseline blood samples from 24 HIV-uninfected Mtb DNA-negative individuals, 24 HIV-uninfected Mtb DNA-positive individuals, and 24 HIV-infected Mtb DNA-positive participants. Analysis was also performed on follow-up blood samples of 24 HIV-infected participants following completion of isoniazid preventive therapy (IPT), of whom 17 were classified as ‘responders’ to IPT (Mtb DNA undetectable at follow-up) and 7 were classified as ‘non-responders’ to IPT (Mtb DNA detectable at follow-up).ResultsCross-sectional analysis of baseline gene expression data from HIV-uninfected participants revealed no differences in Z-scores between Mtb DNA-positive vs. Mtb DNA-negative participants for any of the eight gene expression signatures investigated. Prospective analyses comparing expression of the same eight signatures in HIV-infected participants before vs. after administration of IPT showed no change in gene expression Z-scores over the course of treatment, either for ‘responders’ or ‘non-responders’ to treatment.ConclusionsLack of any association between detection of Mtb DNA in PBMC of asymptomatic TB contacts and presence of gene expression signatures investigated suggests that detection of this bacillary biomarker is more likely to represent quiescent Mtb infection than incipient TB disease.FundingUnited Kingdom Medical Research Council (Ref. MR/P024548/1)RESEARCH IN CONTEXTEvidence before this study□We searched PubMed from database inception to Sept 30, 2023, for studies published in any language evaluating associations between blood RNA signatures for tuberculosis (TB) and biomarkers ofMycobacterium tuberculosis(Mtb) infection using comprehensive terms for “tuberculosis infection”, “latent tuberculosis”, “transcriptional” and “biomarker”. Several reports have described whole blood transcriptional signatures associating with positive Interferon-Gamma Release Assay results in individuals without clinical or radiological evidence of active tuberculosis, but we did not find studies investigating transcriptional correlates of microbial biomarkers of Mtb infection.Added value of this study□To our knowledge, this is the first study to investigate whether detection of Mtb DNA in blood of individuals with asymptomatic tuberculosis infection associates with blood RNA signatures for incipient tuberculosis. Cross-sectional analysis of samples from HIV-uninfected TB contacts in Ethiopia revealed no differences in any of eight whole blood gene expression signatures compared between Mtb DNA-positive vs. Mtb DNA-negative participants. Prospective analyses comparing expression of the same eight signatures in HIV-infected participants before vs. after administration of isoniazid preventive therapy showed no change in gene expression signatures over the course of treatment.Implications of all the available evidence□Lack of any association between detection of Mtb DNA in the blood of asymptomatic TB contacts vs. presence of gene expression signatures for incipient TB provides the best available evidence for bona fide latent Mtb infection.

Publisher

Cold Spring Harbor Laboratory

Reference18 articles.

1. Drain PK , Bajema KL , Dowdy D , et al. Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection. Clinical Microbiology Reviews 2018; 31(4).

2. World Health Organisation. Consensus Meeting Report: Development of a Target Product Profile (TPP) and a framework for evaluation for a test for predicting progression from tuberculosis infection to active disease. Geneva, 2017.

3. Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis;The Lancet Respiratory Medicine,2020

4. Detection of Mycobacterium tuberculosis complex DNA in CD34-positive peripheral blood mononuclear cells of asymptomatic tuberculosis contacts: an observational study;Lancet Microbe,2021

5. van Soolingen D , de Haas PEW , Kremer K. Restriction Fragment Length Polymorphism Typing of Mycobacteria. In: Parish T , Stoker NG , eds. Mycobacterium tuberculosis Protocols. Totowa, NJ: Humana Press; 2001.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3